Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2009 April;168(2) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2009 April;168(2):105-114

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE

A Journal on Internal Medicine and Pharmacology


Indexed/Abstracted in: BIOSIS Previews, EMBASE, Scopus, Emerging Sources Citation Index

 

REVIEWS  


Gazzetta Medica Italiana Archivio per le Scienze Mediche 2009 April;168(2):105-114

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Use of cytostatic and antalgic drugs for the terminal oncological patients: comparison between the years 2000 and 2004

Ghezzo F., Dell’Orco L., Racca S.

Department of Clinical and Biological Sciences S. Luigi Hospital, Orbassano, Turin, Italy


PDF  


Although we cannot yet explain the reason why a person falls sick with cancer and another one does not, we know today environmental factors and characteristics of the lifestyle than can increase our probability of developing the cancer (OI, II). General term by which we define pathologies characterised by a new formation (neoplasy) of a tissue, i.e. the abnormal development of one or more cell masses increasing in an uncontrolled manner. Possible therapies are: surgery, radiotherapy, ormonal therapy, chemoterapy. Pain is one of the most common collateral effects, and the most difficult to resolve with cancer, and it is particularly intense in the terminal patient, i.e. in the cancer patient where the illness has invaded a great part of the organism, and who does not react to any therapy any more.

top of page

Publication History

Cite this article as

Corresponding author e-mail